On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
May 10th 2024
These data suggest that a multidisciplinary clinic approach results in several benefits including reduced risk of cardiovascular events among those with psoriasis.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Heart Disease Linked to Cognitive Decline in Elderly Postmenopaual Women
A recent study published online in the Journal of the American Heart Association discovered an association between cardiovascular disease (CVD) and cognitive decline in postmenopausal women between the ages of 65 and 79 years old.
What Should I Prescribe for This Man's Depression?
January 1st 2014Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.
New Management and Treatment Guidelines Published for Hepatitis C Virus
The European Association for the Study of the Liver published their updated Clinical Practice Guidelines for the management of the hepatitis C virus, which includes updates regarding people who inject recreational drugs.
Pediatrics Group Cautions Against Raw Milk Consumption by Children, Pregnant Women
The American Academy of Pediatrics (AAP) has called for the sale of raw milk to be banned in the United States, as it warned that women, children, and infants should only consume pasteurized milk and milk products.
FDA to Consider Tighter Standards for Generic Epilepsy Drugs
Studies on drug pharmacokinetics in epilepsy patients are being conducted to help the US Food and Drug Administration (FDA) consider whether it needs to tighten bioequivalence rules for generic anti-epilepsy drugs (AEDs) and other medications that have narrow therapeutic windows.
Brintellix Tackles Cognitive Dysfunction Related to Major Depression
In addition to treating episodes of major depression, Brintellix (vortioxentine) has demonstrated superiority to placebo on measures of cognitive function in adult patients with major depressive disorder (MDD).
Increasing NMDA Glutamate Receptor Instead of Blocking It Produces Antidepressant-Like Effects
Results from animal models of depression and a human clinical trial show that enhancing, instead of blocking, the NMDA glutamate receptor can cause antidepressant-like effects.
Within a year of their diagnosis, nearly half of all first-line drug-treated MDD patients were also treated with a second-line therapy, a new study finds. Cymbalta leads the market in second-line therapy, used individually or as a combination, and Abilify is the leading atypical antipsychotic.
Experimental Compound May Reduce Joint Inflammation in Rheumatoid Arthritis
Researchers using mice models have shown that the compound SR2211, which targets a nuclear receptor that is a key regulator of TH17 cells, significantly reduces joint inflammation and erosion.
Thalidomide Extends Remission Duration in Children with Crohn's Disease
A new randomized, double-blind, placebo-controlled study of 56 children with Crohn's disease suggests pediatric patients treated with thalidomide have better rates of remission and response than those given placebo.
Mediterranean Diet as a Primary Prevention of Cardiovascular Disease
December 1st 2013Compared to a low-fat diet, adherence to a Mediterranean diet has significant benefit in the primary prevention of cardiovascular disease among patients aged 55-80 years old at high baseline cardiovascular risk without cardiovascular disease.